Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Eguchi

Showing results (51-60 of 239) with videos related to

Pageof 24
Sort By:
Helicobacter|November 11, 2025
Survey on Awareness of Helicobacter pylori and Gastric Cancer in the Japanese Population Using an Internet SurveyChihiro Matsumoto, Hiroaki Saito, Yoshitaka Nishikawa, et al.
Journal of Clinical Gastroenterology|July 12, 2014
Insulin resistance correlated with the severity of liver histology in Japanese NAFLD patients: a multicenter retrospective studyTakaomi Kessoku, Masato Yoneda, Yoshio Sumida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 23, 2015
Clinical course of hepatitis B surface antigen positive subjects following screening: A retrospective observational study from April 2008 to January 2013Naoko E Furukawa, Shu-Ichi Yamashita, Keishiro Maeyama, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Chronic Hepatitis C Treatment with Daclatasvir Plus Asunaprevir Does Not Lead to a Decreased Quality of LifeMegumi Kawakubo, Yuichiro Eguchi, Michiaki Okada, et al.
Oncology Reports|July 30, 2009
Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogueYasushi Ide, Hao Zhang, Hiroshi Hamajima, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 7, 2007
[Late-onset type ornitine transcarbamirase deficiency (OTCD) with fulminant onset following a fatal prognosis]Tsutomu Yasutake, Daisuke Nagatomo, Toshihiko Mizuta, et al.
Oncology Reports|November 27, 2010
Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-κB activationHao Zhang, Iwata Ozaki, Hiroshi Hamajima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 4, 2012
Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenibTaiga Otsuka, Yuichiro Eguchi, Seiji Kawazoe, et al.
Therapeutic Advances in Gastroenterology|June 19, 2026
Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment: plain language summary of publicationDaisuke Nakamoto, Yi Piao, Manami Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activationIwata Ozaki, Hao Zhang, Toshihiko Mizuta, et al.
Pageof 24

Showing results (51-60 of 239) with videos related to

Sort By:
Pageof 24
Helicobacter|November 11, 2025
Survey on Awareness of Helicobacter pylori and Gastric Cancer in the Japanese Population Using an Internet SurveyChihiro Matsumoto, Hiroaki Saito, Yoshitaka Nishikawa, et al.
Journal of Clinical Gastroenterology|July 12, 2014
Insulin resistance correlated with the severity of liver histology in Japanese NAFLD patients: a multicenter retrospective studyTakaomi Kessoku, Masato Yoneda, Yoshio Sumida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 23, 2015
Clinical course of hepatitis B surface antigen positive subjects following screening: A retrospective observational study from April 2008 to January 2013Naoko E Furukawa, Shu-Ichi Yamashita, Keishiro Maeyama, et al.
Internal Medicine (Tokyo, Japan)|March 13, 2018
Chronic Hepatitis C Treatment with Daclatasvir Plus Asunaprevir Does Not Lead to a Decreased Quality of LifeMegumi Kawakubo, Yuichiro Eguchi, Michiaki Okada, et al.
Oncology Reports|July 30, 2009
Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogueYasushi Ide, Hao Zhang, Hiroshi Hamajima, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|December 7, 2007
[Late-onset type ornitine transcarbamirase deficiency (OTCD) with fulminant onset following a fatal prognosis]Tsutomu Yasutake, Daisuke Nagatomo, Toshihiko Mizuta, et al.
Oncology Reports|November 27, 2010
Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-κB activationHao Zhang, Iwata Ozaki, Hiroshi Hamajima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 4, 2012
Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenibTaiga Otsuka, Yuichiro Eguchi, Seiji Kawazoe, et al.
Therapeutic Advances in Gastroenterology|June 19, 2026
Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment: plain language summary of publicationDaisuke Nakamoto, Yi Piao, Manami Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activationIwata Ozaki, Hao Zhang, Toshihiko Mizuta, et al.
Pageof 24